Effects of d- and l-amphetamine on 5-hydroxytryptamine receptors.
D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000813:Anilides / Q000494:pharmacology; D000818:Animals; D002934:Cinnamates / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004285:Dogs; D066298:In Vitro Techniques; D008684:Metatarsus / Q000098:blood supply; D009119:Muscle Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D009904:Optical Rotation; D010646:Phentolamine / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects*; D012701:Serotonin / Q000502:physiology*; D012702:Serotonin Antagonists; D013329:Structure-Activity Relationship; D013440:Sulfides / Q000494:pharmacology
D000813:Anilides; D002934:Cinnamates; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D012702:Serotonin Antagonists; D013440:Sulfides; D012701:Serotonin; D000661:Amphetamine; D003042:Cocaine; D003913:Dextroamphetamine; D009638:Norepinephrine; D010646:Phentolamine